Anti-Thyroid Drugs Market Report 2026
Anti-Thyroid Drugs Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Anti-Thyroid Drugs Market Report 2026

Global Outlook – By Drug Type (Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)), By Route of Administration (Oral, Intravenous, Other Route Of Administration), By Distribution Channel (Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Anti-Thyroid Drugs Market Overview

• Anti-Thyroid Drugs market size has reached to $2.49 billion in 2025

• Expected to grow to $2.85 billion in 2030 at a compound annual growth rate (CAGR) of 2.9%

• Growth Driver: Increasing Prevalence Of Thyroid Cancer Driving Market Growth Due To Rising Need For Effective Therapeutic Interventions

• Market Trend: Product Innovation Through Monoclonal Antibody Therapies In The Market

North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Anti-Thyroid Drugs Market?

Anti-thyroid drugs refer to agents that function by preventing the manufacture of thyroid hormones or by reducing the action of thyroid hormones. Additionally, they are suggested for use in radioactive iodine uptake tests to assess thyroid function and safeguard the thyroid gland in case of radiation exposure.

The main types of anti-thyroid drugs are thionamides (inhibition of hormone synthesis) and iodides (inhibition of hormone release). Ethionamide drugs pharmacologically normalize thyroid hormone levels. The drugs are administered orally, and intravenously, and others are distributed by wholesalers/distributors, retail chains, online distribution, and others.

Anti-Thyroid Drugs Market Global Report 2026 Market Report bar graph

What Is The Anti-Thyroid Drugs Market Size and Share 2026?

The anti-thyroid drugs market size has grown marginally in recent years. It will grow from $2.49 billion in 2025 to $2.54 billion in 2026 at a compound annual growth rate (CAGR) of 2.0%. The growth in the historic period can be attributed to high prevalence of hyperthyroidism, availability of oral therapies, widespread diagnostic testing, established endocrine care, use in radiation protection.

What Is The Anti-Thyroid Drugs Market Growth Forecast?

The anti-thyroid drugs market size is expected to see steady growth in the next few years. It will grow to $2.85 billion in 2030 at a compound annual growth rate (CAGR) of 2.9%. The growth in the forecast period can be attributed to growth in autoimmune thyroid diseases, improved screening programs, rising healthcare access, innovation in thyroid regulation therapies, aging population. Major trends in the forecast period include rising diagnosis of thyroid disorders, growing use of thionamide-based drugs, expansion of outpatient thyroid management, increased monitoring of hormone levels, improved drug safety profiles.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Anti-Thyroid Drugs Market Segmentation

1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

Subsegments:

1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol's Iodine Solution

What Is The Driver Of The Anti-Thyroid Drugs Market?

The increasing prevalence of thyroid cancer is expected to drive the growth of the anti-thyroid drugs going forward. Thyroid cancer is a disease in the thyroid gland (a gland near the base of the throat that produces hormones to help regulate body temperature, heart rate, blood pressure, and weight). The rising prevalence of thyroid cancer is primarily due to greater exposure to medical radiation and environmental carcinogens. Anti-thyroid drugs help to discover thyroid cancer by providing early detection that can help improve treatment outcomes. For instance, in August 2023, according to the American Society of Clinical Oncology, a US-based community for oncologists and surgeons, in the United States, an estimated 43,720 adults (12,540 men and 31,180 women) were diagnosed with thyroid cancer in 2023, and an estimated 2,120 deaths (970 men and 1,150 women) from this disease were expected to occur in the same year. Therefore, the increasing prevalence of thyroid cancer is propelling the growth of the anti-thyroid drugs industry.

Key Players In The Global Anti-Thyroid Drugs Market

Major companies operating in the anti-thyroid drugs market are Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., Pfizer Inc., Allergan plc, RLC LABS Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Aspen Pharmacare Holdings Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

Global Anti-Thyroid Drugs Market Trends and Insights

Major companies operating in the anti-thyroid drugs market are focusing on innovating products, such as monoclonal antibodies, to improve patient outcomes, reduce adverse effects, and strengthen their competitive position. Monoclonal antibodies refer to laboratory-engineered proteins that precisely target specific molecules in the body to help treat diseases more effectively. For instance, in March 2025, Innovent Biologics, Inc., a China-based biotechnology company, announced the approval of SYCUME, an anti-IGF-1R monoclonal antibody, by China's National Medical Products Administration (NMPA) for the treatment of thyroid eye disease (TED). SYCUME is the first drug of its kind approved in China and the second worldwide, offering a new, effective treatment option that significantly reduces proptosis and inflammation while improving patients' quality of life. The approval is based on positive clinical trial results demonstrating SYCUME’s ability to address the unmet needs of TED patients, providing a safer, more accessible alternative to existing therapies.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Anti-Thyroid Drugs Market?

In October 2023, Amgen Inc., a US-based biotechnology company, acquired Horizon Therapeutics plc, for approximately $27.8 billion. Through this acquisition, Amgen aims to enhance its anti-thyroid drugs portfolio by integrating Horizon Therapeutics’ innovative therapies for thyroid disorders, enabling the development of advanced treatments for patients with hyperthyroidism and other thyroid-related conditions. Horizon Therapeutics plc is an Ireland-based biopharmaceutical company specializing in rare and specialty diseases with a strong track record in developing anti-thyroid drugs and endocrine disorders.

Regional Insights

North America was the largest region in the anti-thyroid drugs market in 2025. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anti-Thyroid Drugs Market?

The anti-thyroid drugs market consists of sales of levothyroxine, propylthiouracil, and methimazole. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anti-Thyroid Drugs Market Report 2026?

The anti-thyroid drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anti-thyroid drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Anti-Thyroid Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $2.54 billion
Revenue Forecast In 2035 $2.85 billion
Growth Rate CAGR of 2.0% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Type, Route of Administration, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., Pfizer Inc., Allergan plc, RLC LABS Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Aspen Pharmacare Holdings Limited, Aurobindo Pharma Limited,
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Anti-Thyroid Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Anti-Thyroid Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Anti-Thyroid Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Anti-Thyroid Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Rising Diagnosis Of Thyroid Disorders

4.2.2 Growing Use Of Thionamide-Based Drugs

4.2.3 Expansion Of Outpatient Thyroid Management

4.2.4 Increased Monitoring Of Hormone Levels

4.2.5 Improved Drug Safety Profiles

5. Anti-Thyroid Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Endocrinology Clinics

5.3 Diagnostic Centers

5.4 Retail Pharmacies

5.5 Specialty Clinics

6. Anti-Thyroid Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Anti-Thyroid Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Anti-Thyroid Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Anti-Thyroid Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Anti-Thyroid Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Anti-Thyroid Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Anti-Thyroid Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Anti-Thyroid Drugs Market Segmentation

9.1. Global Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

9.2. Global Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous, Other Route Of Administration

9.3. Global Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

9.4. Global Anti-Thyroid Drugs Market, Sub-Segmentation Of Thionamides (Inhibition Of Hormone Synthesis), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Methimazole, Propylthiouracil

9.5. Global Anti-Thyroid Drugs Market, Sub-Segmentation Of Iodides (Inhibition Of Hormone Release), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Potassium Iodide, Lugol's Iodine Solution

10. Anti-Thyroid Drugs Market Regional And Country Analysis

10.1. Global Anti-Thyroid Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Anti-Thyroid Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Anti-Thyroid Drugs Market

11.1. Asia-Pacific Anti-Thyroid Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Anti-Thyroid Drugs Market

12.1. China Anti-Thyroid Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Anti-Thyroid Drugs Market

13.1. India Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Anti-Thyroid Drugs Market

14.1. Japan Anti-Thyroid Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Anti-Thyroid Drugs Market

15.1. Australia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Anti-Thyroid Drugs Market

16.1. Indonesia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Anti-Thyroid Drugs Market

17.1. South Korea Anti-Thyroid Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Anti-Thyroid Drugs Market

18.1. Taiwan Anti-Thyroid Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Anti-Thyroid Drugs Market

19.1. South East Asia Anti-Thyroid Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Anti-Thyroid Drugs Market

20.1. Western Europe Anti-Thyroid Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Anti-Thyroid Drugs Market

21.1. UK Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Anti-Thyroid Drugs Market

22.1. Germany Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Anti-Thyroid Drugs Market

23.1. France Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Anti-Thyroid Drugs Market

24.1. Italy Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Anti-Thyroid Drugs Market

25.1. Spain Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Anti-Thyroid Drugs Market

26.1. Eastern Europe Anti-Thyroid Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Anti-Thyroid Drugs Market

27.1. Russia Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Anti-Thyroid Drugs Market

28.1. North America Anti-Thyroid Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Anti-Thyroid Drugs Market

29.1. USA Anti-Thyroid Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Anti-Thyroid Drugs Market

30.1. Canada Anti-Thyroid Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Anti-Thyroid Drugs Market

31.1. South America Anti-Thyroid Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Anti-Thyroid Drugs Market

32.1. Brazil Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Anti-Thyroid Drugs Market

33.1. Middle East Anti-Thyroid Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Anti-Thyroid Drugs Market

34.1. Africa Anti-Thyroid Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Anti-Thyroid Drugs Market, Segmentation By Drug Type, Segmentation By Route of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Anti-Thyroid Drugs Market Regulatory and Investment Landscape

36. Anti-Thyroid Drugs Market Competitive Landscape And Company Profiles

36.1. Anti-Thyroid Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Anti-Thyroid Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Anti-Thyroid Drugs Market Company Profiles

36.3.1. Mylan N.V. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Anti-Thyroid Drugs Market Other Major And Innovative Companies

Allergan plc, RLC LABS Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Aspen Pharmacare Holdings Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd.

38. Global Anti-Thyroid Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Anti-Thyroid Drugs Market

40. Anti-Thyroid Drugs Market High Potential Countries, Segments and Strategies

40.1 Anti-Thyroid Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Anti-Thyroid Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Anti-Thyroid Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Anti-Thyroid Drugs Market, Overview Of Key Products - Product Examples
  • Table 2: Global Anti-Thyroid Drugs Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Anti-Thyroid Drugs Market, Supply Chain Analysis
  • Table 4: Global Anti-Thyroid Drugs Market, Major Raw Material Providers
  • Table 5: Global Anti-Thyroid Drugs Market, Major Resource Providers
  • Table 6: Global Anti-Thyroid Drugs Market, Major Manufacturers (Suppliers)
  • Table 7: Global Anti-Thyroid Drugs Market, Major Distributors And Channel Partners
  • Table 8: Global Anti-Thyroid Drugs Market, Key Technologies & Future Trends
  • Table 9: Global Anti-Thyroid Drugs Market, Major Trends
  • Table 10: Global Anti-Thyroid Drugs Market, Major End Users
  • Table 11: Global Anti-Thyroid Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Anti-Thyroid Drugs Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Anti-Thyroid Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Anti-Thyroid Drugs Market - TAM, US$ Billion, 2025
  • Table 15: Global Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Anti-Thyroid Drugs Market, Sub-Segmentation Of Thionamides (Inhibition Of Hormone Synthesis), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Anti-Thyroid Drugs Market, Sub-Segmentation Of Iodides (Inhibition Of Hormone Release), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Anti-Thyroid Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Anti-Thyroid Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Anti-Thyroid Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Anti-Thyroid Drugs Market - Company Scoring Matrix
  • Table 96: Mylan N.V. Financial Performance
  • Table 97: Abbott Laboratories Financial Performance
  • Table 98: GlaxoSmithKline plc Financial Performance
  • Table 99: Merck & Co. Financial Performance
  • Table 100: Pfizer Inc. Financial Performance
  • Table 101: Global Anti-Thyroid Drugs Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Anti-Thyroid Drugs Market, Competitive Dashboard
  • Table 103: Global Anti-Thyroid Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Anti-Thyroid Drugs Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030
  • Table 105: Global, Anti-Thyroid Drugs Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030
  • Table 106: Global, Anti-Thyroid Drugs Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Anti-Thyroid Drugs Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Anti-Thyroid Drugs Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Anti-Thyroid Drugs Market, Supply Chain Analysis
  • Figure 4: Global Anti-Thyroid Drugs Market, Major Raw Material Providers
  • Figure 5: Global Anti-Thyroid Drugs Market, Major Resource Providers
  • Figure 6: Global Anti-Thyroid Drugs Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Anti-Thyroid Drugs Market, Major Distributors And Channel Partners
  • Figure 8: Global Anti-Thyroid Drugs Market, Key Technologies & Future Trends
  • Figure 9: Global Anti-Thyroid Drugs Market, Major Trends
  • Figure 10: Global Anti-Thyroid Drugs Market, Major End Users
  • Figure 11: Global Anti-Thyroid Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Anti-Thyroid Drugs Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Anti-Thyroid Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Anti-Thyroid Drugs Market - TAM, US$ Billion, 2025
  • Figure 15: Global Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Anti-Thyroid Drugs Market, Sub-Segmentation Of Thionamides (Inhibition Of Hormone Synthesis), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Anti-Thyroid Drugs Market, Sub-Segmentation Of Iodides (Inhibition Of Hormone Release), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Anti-Thyroid Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Anti-Thyroid Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Anti-Thyroid Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Anti-Thyroid Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Anti-Thyroid Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Anti-Thyroid Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Anti-Thyroid Drugs Market - Company Scoring Matrix
  • Figure 96: Mylan N.V. Financial Performance
  • Figure 97: Abbott Laboratories Financial Performance
  • Figure 98: GlaxoSmithKline plc Financial Performance
  • Figure 99: Merck & Co. Financial Performance
  • Figure 100: Pfizer Inc. Financial Performance
  • Figure 101: Global Anti-Thyroid Drugs Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Anti-Thyroid Drugs Market, Competitive Dashboard
  • Figure 103: Global Anti-Thyroid Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Anti-Thyroid Drugs Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030
  • Figure 105: Global, Anti-Thyroid Drugs Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030
  • Figure 106: Global, Anti-Thyroid Drugs Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Frequently Asked Questions

The Anti-Thyroid Drugs market was valued at $2.49 billion in 2025, increased to $2.54 billion in 2026, and is projected to reach $2.85 billion by 2030.

The global Anti-Thyroid Drugs market is expected to grow at a CAGR of 2.9% from 2026 to 2035 to reach $2.85 billion by 2035.

Some Key Players in the Anti-Thyroid Drugs market Include, Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., Pfizer Inc., Allergan plc, RLC LABS Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Aspen Pharmacare Holdings Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc. .

Major trend in this market includes: Product Innovation Through Monoclonal Antibody Therapies In The Market. For further insights on this market. request a sample here

North America was the largest region in the anti-thyroid drugs market in 2025. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts